Blockade of myocardial ATP-sensitive potassium channels by ketamine. 1997

S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
Chonbuk National University Medical School, Keum-Am Dong Chonju, Korea.

BACKGROUND The adenosine triphosphate (ATP)-sensitive potassium (KATP) channel underlies the increase in potassium permeability during hypoxia and ischemia. The increased outward potassium current during ischemia may be an endogenous cardioprotective mechanism. This study was designed to determine the effects of ketamine on KATP channel in rat hearts. METHODS Inside-out and cell-attached configurations of patch-clamp techniques and 3 M potassium chloride-filled conventional microelectrodes were used to investigate the effect of ketamine on KATP channel currents in single rat ventricular myocytes and on the action potential duration of rat papillary muscles, respectively. RESULTS Ketamine inhibited KATP channel activity in rat ventricular myocytes in a concentration-dependent manner. In the inside-out patches, the concentration of ketamine for half-maximal inhibition and the Hill coefficient were 62.9 microM and 0.54, respectively. In a concentration-dependent manner, ketamine inhibited pinacidil- and 2,4-dinitrophenol-activated KATP channels in cell-attached patches. The application of ketamine to the intracellular side of membrane patches did not affect the conduction of single-channel currents of KATP channels. Ketamine increased the action potential duration, which was then shortened by pinacidil in a concentration-dependent manner. CONCLUSIONS Ketamine inhibited KATP channel activity in a concentration-dependent manner. These results suggest that ketamine may attenuate the cardioprotective effects of the KATP channel during ischemia and reperfusion in the rat myocardium.

UI MeSH Term Description Entries
D007649 Ketamine A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI-581,Calipsol,Calypsol,Kalipsol,Ketalar,Ketamine Hydrochloride,Ketanest,Ketaset,CI 581,CI581
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000778 Anesthetics, Dissociative Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Dissociative Anesthetics
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel
D015640 Ion Channel Gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability. Gating, Ion Channel,Gatings, Ion Channel,Ion Channel Gatings

Related Publications

S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
February 1992, Circulation research,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
October 1992, Brain research,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
January 1995, Basic research in cardiology,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
February 2005, Journal of molecular and cellular cardiology,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
January 2005, Current pharmaceutical design,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
January 1999, Methods in enzymology,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
October 1994, Cardiovascular drugs and therapy,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
July 1995, Journal of cardiac surgery,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
December 1998, International journal of cardiology,
S H Ko, and S K Lee, and Y J Han, and H Choe, and Y G Kwak, and S W Chae, and K P Cho, and H S Song
December 2004, British journal of pharmacology,
Copied contents to your clipboard!